157 related articles for article (PubMed ID: 15950650)
21. Compliance considerations with hormone replacement therapy.
Karakoç B; Erenus M
Menopause; 1998; 5(2):102-6. PubMed ID: 9689204
[TBL] [Abstract][Full Text] [Related]
22. Duration not severity of the climacteric syndrome predicts resumption of hormone therapy after discontinuation: a prospective cohort study.
Haimov-Kochman R; Barak-Glantz E; Ein-Mor E; Arbel R; Brzezinski A; Milwidsky A; Hochner-Celnikier D
Hum Reprod; 2006 Sep; 21(9):2450-4. PubMed ID: 16731546
[TBL] [Abstract][Full Text] [Related]
23. Personality and hormone therapy use among postmenopausal women in the GAZEL cohort study.
Lemogne C; Consoli SM; Panjo H; Nabi H; Goldberg M; Zins M; Ringa V
Fertil Steril; 2012 Oct; 98(4):929-36. PubMed ID: 22763102
[TBL] [Abstract][Full Text] [Related]
24. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
25. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
Rigby AJ; Ma J; Stafford RS
Menopause; 2007; 14(5):853-8. PubMed ID: 17429334
[TBL] [Abstract][Full Text] [Related]
26. Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts.
Fournier A; Kernaleguen C; Panjo H; Clavel-Chapelon F; Ringa V
Menopause; 2011 Feb; 18(2):219-23. PubMed ID: 21052030
[TBL] [Abstract][Full Text] [Related]
27. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
Ushiroyama T; Ikeda A; Sakuma K; Ueki M
J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
[TBL] [Abstract][Full Text] [Related]
28. Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?
Haskell SG; Bean-Mayberry B; Gordon K
Menopause; 2009; 16(3):494-9. PubMed ID: 19182695
[TBL] [Abstract][Full Text] [Related]
29. Women's trust in and use of information sources in the treatment of menopausal symptoms.
Huston SA; Jackowski RM; Kirking DM
Womens Health Issues; 2009; 19(2):144-53. PubMed ID: 19272565
[TBL] [Abstract][Full Text] [Related]
30. Life after the women's health initiative: evaluation of postmenopausal symptoms and use of alternative therapies after discontinuation of hormone therapy.
Shrader SP; Ragucci KR
Pharmacotherapy; 2006 Oct; 26(10):1403-9. PubMed ID: 16999650
[TBL] [Abstract][Full Text] [Related]
31. Risks of hormone therapy in the 50-59 year age group.
van de Weijer PH
Maturitas; 2008 May; 60(1):59-64. PubMed ID: 18556157
[TBL] [Abstract][Full Text] [Related]
32. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
[TBL] [Abstract][Full Text] [Related]
33. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.
Hoffmann M; Hammar M; Kjellgren KI; Lindh-Astrand L; Brynhildsen J
Maturitas; 2005 Sep; 52(1):11-7. PubMed ID: 16023804
[TBL] [Abstract][Full Text] [Related]
34. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
Schonberg MA; Davis RB; Wee CC
Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
[TBL] [Abstract][Full Text] [Related]
35. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
[TBL] [Abstract][Full Text] [Related]
36. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
[TBL] [Abstract][Full Text] [Related]
37. Understanding the menopausal experiences of professional women.
Simon JA; Reape KZ
Menopause; 2009; 16(1):73-6. PubMed ID: 18779760
[TBL] [Abstract][Full Text] [Related]
38. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
Bakken K; Eggen AE; Lund E
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
[TBL] [Abstract][Full Text] [Related]
39. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
40. The effect of education and counseling services on compliance to therapy of women taking hormone therapy for the first time.
Akkuzu G; Eroğlu K
Menopause; 2005; 12(6):763-73. PubMed ID: 16278621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]